Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 14.4512.358.4110.144.33

What is the latest EV/Core EBITDA ratio of SMS PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SMS PHARMACEUTICALS is 14.45 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202414.45
Mar202312.35
Mar20228.41
Mar202110.14
Mar20204.33

How is EV/Core EBITDA of SMS PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 14.45
17.00
Mar2023 12.35
46.85
Mar2022 8.41
-17.06
Mar2021 10.14
134.18
Mar2020 4.33 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹2,062.9 Cr -3.9% -7.2% 109.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,361.0 Cr -1.4% 1.2% 46.9% Stock Analytics
DIVIS LABORATORIES ₹155,274.0 Cr -1.4% 1.8% 60% Stock Analytics
CIPLA ₹117,144.0 Cr -0.3% -3.3% 19.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,134.0 Cr 0.8% 1.8% 13.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,554.4 Cr -1.7% 1.2% 53.9% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

-3.9%

-7.2%

109.4%

SENSEX

-1%

3.9%

16%


You may also like the below Video Courses